CUSTOMERS of a Millicent pharmacy are disappointed that all codeine containing medicines can no longer be purchased over the counter.
As part of a nationwide requirement, such medicines have to be authorised by a doctor via a script.
The changes took effect across Australia on February 1, but Millicent Chemist and Giftware co-proprietor Usman Hameed said some of his customers have expressed their disappointment with the changes.
“They accept that it is the law and now they have to go and see a GP or go to the hospital for the medicines containing codeine,” Mr Hameed said.
“For the past year, all codeine containing medicines have only been dispensed following the intervention of the pharmacist.
“We have provided face-to-face counselling as well as the real-time monitoring of such purchases.
“The most common codeine containing medicines are Panadeine and Nurofen Plus.
“They have always been kept behind the counter and away from public view.”
The shop in George Street experienced a higher demand for codeine containing products in the lead-up to February 1 but there was “no rush” as had been reported at pharmacies elsewhere across the nation.
Mr Hameed gave the example of post-operative patients who may be in need of pain relief.
“We were able to help them but now they need to see a doctor or a hospital,” he said.
“We never abused the sale of the codeine containing medicines as we believe in ethical practices.
“If people suffered from chronic pain, we would advise them to see a doctor as there may be some underlying problems.”
He does not disguise his disagreement with the decision of the health authorities.
“As a pharmacist, I hate codeine products due to the possible side effects,” he said.
“But without providing alternative pathways to help people, it is not a good move to take accessibility away from patients.”
Customer Christine Baker, of Tantanoola, does not use any codeine containing medicines, but has welcomed the changes.
“It is not a bad idea to require a doctor’s prescription considering the misuse of drugs nowadays,” Ms Baker said.
Rural Doctors Association of Australia president Doctor Adam Coltzau said the nationwide changes would result in positive outcomes for patients.
“Many people are unaware that low dose codeine is actually largely ineffective treating many conditions causing pain,” Dr Coltzau said.
“Reassessing pain management strategies should result in improved health outcomes for those struggling with chronic pain.
“Regular users of low dose codeine products previously available over the counter should consult with their pharmacist, nurse or doctor regarding other options that may be more effective, as well as more safe.”
Dr Coltzau said for ongoing pain a combination of strategies to suit the condition would achieve the best outcome.
“Medication alone is not effective and multidisciplinary pain management will address all of the factors associated with pain including mental health, social relationships and work,” he said.
“Also, importantly, there are many patients out there who are suffering pain and have not consulted their health practitioner about it.
“If the codeine up scheduling prompts these people to visit their doctor or review their medication with their pharmacist, it will allow assessment and better treatment and management of their underlying condition.”
